Literature DB >> 826117

Effect of aurothiomalate on human mononuclear blood cells cultured in vitro.

K E Viken, J O Lamvik.   

Abstract

Human mononuclear phagocytes were exposed to aurothiomalate in various concentrations and at various stages in the differentiation from monocytes to macrophages in vitro. Monocytes exposed to aurothiomalate during the first 90 minutes of culture showed impaired engulfment capacity when tested 8 days after the exposure to the drug. It was found that aurothiomalate suppressed the digestion capacity in differentiated macrophages while the engulfment capacity was unaffected by the drug. During the period of differentiation from 90 minutes to 8 days of culture, exposure to aurothiomalate resulted in a dose dependent reduction in cell survival and differentiation. The effect of aurothiomalate on the blastoid transformation of lymphocytes following BCG stimulation was also tested. A strong and dose dependent inhibition of DNA synthesis was recorded. The inhibition of phagocytosis in mononuclear phagocytes and the inhibition of antigen-induced lymphocyte stimulation as demonstrated may help to explain the effect of aurothiomalate in patients suffering from rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826117     DOI: 10.1111/j.1699-0463.1976.tb00050.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  3 in total

1.  In vitro effects of gold sodium thiomalate on IL-1, IL-2 production, IL-2 receptor expression and IL-2 responsiveness in thymocytes and peripheral blood mononuclear cells.

Authors:  E Blitstein-Willinger; A Streller
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

2.  Sodium aurothiomalate does not block interleukin 1 production in rabbits.

Authors:  Y Zurovsky; H P Laburn; D Mitchell; A Ruck
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

3.  Effect of in vivo administration of gold sodium thiomalate on rat macrophage function.

Authors:  R M Turkall; G A Warr; M F Tsan
Journal:  Agents Actions       Date:  1982-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.